Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Butyryl-Histone H2B (Lys20) Antibody (1L884)
Catalog No. TMAB-03265 Copy Product Info
🥰Excellent
Anti-Butyryl-Histone H2B (Lys20) Antibody (1L884) is a Mouse antibody targeting Butyryl-Histone H2B (Lys20). Anti-Butyryl-Histone H2B (Lys20) Antibody (1L884) can be used in WB,IHC-P,IHC-Fr,IF.
Anti-Butyryl-Histone H2B (Lys20) Antibody (1L884)
Copy Product Info🥰Excellent
Catalog No. TMAB-03265
Anti-Butyryl-Histone H2B (Lys20) Antibody (1L884) is a Mouse antibody targeting Butyryl-Histone H2B (Lys20). Anti-Butyryl-Histone H2B (Lys20) Antibody (1L884) can be used in WB,IHC-P,IHC-Fr,IF.
Anti-Butyryl-Histone H2B
(Lys20) Antibody
(1L884)
(Lys20) Antibody
(1L884)
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 50 μL | $298 | 7-10 days | 7-10 days | |
| 100 μL | $470 | 7-10 days | 7-10 days |
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Stability & Storage
| Description | Anti-Butyryl-Histone H2B (Lys20) Antibody (1L884) is a Mouse antibody targeting Butyryl-Histone H2B (Lys20). Anti-Butyryl-Histone H2B (Lys20) Antibody (1L884) can be used in WB,IHC-P,IHC-Fr,IF. |
| Ig Type | IgG |
| Clone | 1L884 |
| Reactivity | Human (predicted:Mouse,Rat) |
| Verified Activity | Blocking buffer: 5% NFDM/TBST Primary ab dilution: 1: 2000 Primary ab incubation condition: 2 hours at room temperature Secondary ab: Goat Anti-Mouse IgG H&L (HRP) Lysate: (-) HeLa, (+) HeLa+Sodium butyrate (30 mM, 4 h) Protein loading quantity: 20 μg Exposure time: 60 s Predicted MW: 14 kDa Observed MW: 14 kDa |
| Application | |
| Recommended Dose | WB: 1:500-2000; IHC-P: 1:100-500; IHC-Fr: 1:100-500; IF: 1:100-500 |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | Hybridoma Monoclonal Antibody |
| Purification | Antigen affinity purification |
| Appearance | Liquid |
| Formulation | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Concentration | 1mg/ml |
| Research Background | Histone post-translational modifications (PTMs) are key mechanisms in epigenetic regulation of chromatin structure, often referred to as the “histone code.” PTMs on histones include acetylation, methylation, phosphorylation, and several novel acylation modifications discovered in recent years. These histone modifications directly influence chromatin structure and the binding of transcription factors or other epigenetic regulators, thereby altering genomic stability and gene transcription. Histone methylation typically occurs on lysine and arginine residues of core histones. It can either promote or inhibit gene transcription, depending on whether methylation occurs on lysine or arginine residues and the number of methyl groups present (lysines can be mono-, di-, or trimethylated, while arginines can undergo mono-, symmetric, or asymmetric dimethylation). Lysine methylation in histones commonly occurs at lysine residues 4, 9, 27, 36, and 79 of histone H3, and at lysine 20 of histone H4. Arginine methylation typically occurs at arginine residues 2, 8, 17, and 26 of histone H3, and at arginine 3 of histone H4. Histone methyltransferases (HMTs) and histone demethylases (HDMs) are the primary regulators of methylation modifications. |
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
Calculator
Preview
Related Tags: buy Anti-Butyryl-Histone H2B (Lys20) Antibody (1L884) | purchase Anti-Butyryl-Histone H2B (Lys20) Antibody (1L884) | Anti-Butyryl-Histone H2B (Lys20) Antibody (1L884) cost | order Anti-Butyryl-Histone H2B (Lys20) Antibody (1L884)
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.